FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2296095373> ?p ?o ?g. }

• W2296095373 endingPage "33450" @default.
• W2296095373 startingPage "33440" @default.
• W2296095373 abstract "// Xiaoman Li 1,* , Changjing Wu 1,* , Nianci Chen 2 , Huadi Gu 3 , Allen Yen 4 , Liu Cao 1 , Enhua Wang 3,5 and Liang Wang 3,5 1 Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China 2 Class 9 of the 97th Clinical Medicine of Seven-Year Program, China Medical University, Shenyang, China 3 Department of Pathology, The College of Basic Medical Sciences, China Medical University, Shenyang, China 4 School of Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America 5 Department of Pathology, The First Affiliated Hospital of China Medical University, Shenyang, China * These authors have contributed equally to this work Correspondence to: Liang Wang, email: // Keywords : glioblastoma, EGFR, PI3K/Akt/mTOR pathway, targeted therapy Received : December 05, 2015 Accepted : February 24, 2016 Published : March 07, 2016 Abstract Glioblastoma multiform (GBM) is the most common malignant glioma of all the brain tumors and currently effective treatment options are still lacking. GBM is frequently accompanied with overexpression and/or mutation of epidermal growth factor receptor (EGFR), which subsequently leads to activation of many downstream signal pathways such as phosphatidylinositol 3-kinase (PI3K)/Akt/rapamycin-sensitive mTOR-complex (mTOR) pathway. Here we explored the reason why inhibition of the pathway may serve as a compelling therapeutic target for the disease, and provided an update data of EFGR and PI3K/Akt/mTOR inhibitors in clinical trials." @default.
• W2296095373 created "2016-06-24" @default.
• W2296095373 creator A5011588599 @default.
• W2296095373 creator A5012308772 @default.
• W2296095373 creator A5023811312 @default.
• W2296095373 creator A5034418164 @default.
• W2296095373 creator A5064091856 @default.
• W2296095373 creator A5086664647 @default.
• W2296095373 creator A5088481321 @default.
• W2296095373 creator A5091520589 @default.
• W2296095373 date "2016-03-07" @default.
• W2296095373 modified "2023-10-02" @default.
• W2296095373 title "PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma" @default.
• W2296095373 cites W1498815591 @default.
• W2296095373 cites W1529396499 @default.
• W2296095373 cites W1531128472 @default.
• W2296095373 cites W1587932799 @default.
• W2296095373 cites W1874566015 @default.
• W2296095373 cites W1964073090 @default.
• W2296095373 cites W1969752146 @default.
• W2296095373 cites W1977267072 @default.
• W2296095373 cites W1981711832 @default.
• W2296095373 cites W1983516907 @default.
• W2296095373 cites W1989008399 @default.
• W2296095373 cites W1994520319 @default.
• W2296095373 cites W1997199834 @default.
• W2296095373 cites W2000954296 @default.
• W2296095373 cites W2005496215 @default.
• W2296095373 cites W2005661588 @default.
• W2296095373 cites W2006771504 @default.
• W2296095373 cites W2008577371 @default.
• W2296095373 cites W2009886463 @default.
• W2296095373 cites W2013878898 @default.
• W2296095373 cites W2024158973 @default.
• W2296095373 cites W2026370041 @default.
• W2296095373 cites W2036044314 @default.
• W2296095373 cites W2038657036 @default.
• W2296095373 cites W2040827479 @default.
• W2296095373 cites W2045975323 @default.
• W2296095373 cites W2047764045 @default.
• W2296095373 cites W2054455334 @default.
• W2296095373 cites W2059352954 @default.
• W2296095373 cites W2061760261 @default.
• W2296095373 cites W2070151637 @default.
• W2296095373 cites W2070705072 @default.
• W2296095373 cites W2071289226 @default.
• W2296095373 cites W2080100938 @default.
• W2296095373 cites W2080127092 @default.
• W2296095373 cites W2085483616 @default.
• W2296095373 cites W2086216067 @default.
• W2296095373 cites W2087012714 @default.
• W2296095373 cites W2091913780 @default.
• W2296095373 cites W2094224485 @default.
• W2296095373 cites W2096287682 @default.
• W2296095373 cites W2099283141 @default.
• W2296095373 cites W2102348612 @default.
• W2296095373 cites W2102839088 @default.
• W2296095373 cites W2104743043 @default.
• W2296095373 cites W2105150451 @default.
• W2296095373 cites W2109467838 @default.
• W2296095373 cites W2110700617 @default.
• W2296095373 cites W2110949408 @default.
• W2296095373 cites W2116622644 @default.
• W2296095373 cites W2125096000 @default.
• W2296095373 cites W2126569401 @default.
• W2296095373 cites W2129172946 @default.
• W2296095373 cites W2129585918 @default.
• W2296095373 cites W2132279561 @default.
• W2296095373 cites W2132607958 @default.
• W2296095373 cites W2134818675 @default.
• W2296095373 cites W2136734008 @default.
• W2296095373 cites W2138504960 @default.
• W2296095373 cites W2138951875 @default.
• W2296095373 cites W2139203226 @default.
• W2296095373 cites W2143739956 @default.
• W2296095373 cites W2147775209 @default.
• W2296095373 cites W2148977460 @default.
• W2296095373 cites W2149498660 @default.
• W2296095373 cites W2151010413 @default.
• W2296095373 cites W2154836325 @default.
• W2296095373 cites W2155009617 @default.
• W2296095373 cites W2155045369 @default.
• W2296095373 cites W2156778785 @default.
• W2296095373 cites W2158106887 @default.
• W2296095373 cites W2158305336 @default.
• W2296095373 cites W2158681922 @default.
• W2296095373 cites W2162584257 @default.
• W2296095373 cites W2164882663 @default.
• W2296095373 cites W2165123465 @default.
• W2296095373 cites W2165254737 @default.
• W2296095373 cites W2165404212 @default.
• W2296095373 cites W2165424687 @default.
• W2296095373 cites W2165871546 @default.
• W2296095373 cites W2166476411 @default.
• W2296095373 cites W2167010784 @default.
• W2296095373 cites W2168687763 @default.
• W2296095373 cites W2239149852 @default.
• W2296095373 cites W2312553905 @default.

• next